Release Date: 03/04/14 09:02 Summary: Emerging Companies Conference Presentation Price Sensitive: No Download Document 472.76KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%